Overall Survival, Progression-Free Survival, and Tumor Response Benefit Supporting Initial US Food and Drug Administration Approval and Indication Extension of New Cancer Drugs, 2003-2021 Patients ...
Precision medicine involves biomarker-directed therapeutic strategies that optimize the risk-benefit ratio for each patient. Implementation of precision medicine requires biomarker-driven randomized ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback